Loading clinical trials...

Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT | Clinical Trials | Clareo Health

COMPLETEDNCT06265883

Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT

This multicenter retrospective study evaluated consecutive patients with large HCC and PVTT who received lenvatinib plus DEB-TACE with/without FOLFOX-HAIC between July 2019 and June 2021. Tumor respon...

Lead sponsor: Second Affiliated Hospital of Guangzhou Medical University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 3

Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT

NCT06492395 · Hepatocellular Carcinoma Non-resectable

RECRUITINGPhase 2

Y-90 SIRT for Unresectable HCC Larger Than 7cm

NCT06707233 · Hepatocellular Carcinoma Non-Resectable

RECRUITINGNA

BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC)

NCT05911633 · Hepatocellular Carcinoma Non-resectable

RECRUITINGPhase 2

Combined HAIC, Lenvatinib and Cadonilimab As Conversion Therapy for Unresectable Hepatocellular Carcinoma

NCT06187961 · Hepatocellular Carcinoma Non-resectable

RECRUITING

Triple Therapy Sequential Radiotherapy in Unresectable HCC (TALENP003)

NCT06561399 · Hepatocellular Carcinoma Non-resectable

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 20, 2024Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment205

Start dateJul 2019

Last updatedFeb 20, 2024

Condition

Hepatocellular Carcinoma Non-resectable

Locations shown

The Second Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 20, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions